Amrit Ray - Apr 19, 2022 Form 3 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
Director
Signature
/s/ Karah Parschauer, attorney-in-fact
Stock symbol
RARE
Transactions as of
Apr 19, 2022
Transactions value $
$0
Form type
3
Date filed
4/22/2022, 12:30 PM
Next filing
Jun 28, 2022

No securities are beneficially owned.

Remarks:

No securities beneficially owned